JR
JRSIS Health Care Corporation
JRSS · OTC
$0.02 +0.00% (+$0.00)
Market Cap $1.27M
P/E Ratio -
Div. Yield -
ROE -
Bulios Fair Price
$0.01
33.3% downside
Current Price
$0.015
Undervalued Fair Value Overvalued
According to Bulios Fair Price, JRSS is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
1/9Valuation
29 /100
Expensive P/S 5.62x
EV/FFO N/A
P/E N/A
Growth
100 /100
Growing Rev. growth 53.14%
Book val. growth N/A
EPS growth N/A
Profitability
4 /100
Weak Op. margin 3.95%
Gross margin 16.04%
FCF margin 63.41%
Quality
32 /100
Poor Asset turnover 0.70x
ROIC 6.61%
ROA 2.57%
Debt
0 /100
High Current ratio 0.32x
Net debt/EBITDA N/A
Debt/Equity N/A
Stability
28 /100
Unstable EPS volatility 346.84%
Beta 0.68x
Profitable years 1
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about JRSS
Online
Sector
Healthcare
Industry
Medical - Care Facilities
CEO
Linhai Zhu
Employees
36
Headquarters
Yongzhou